The physiologically-based framework allows integration of multi-scale data leading to build-up and transfer of actionable knowledge across all phases of drug research & development within one single platform.
The integrated database on animal and human physiology allows translation of experimental results from preclinical research to clinical development for a more efficient use of cost effective animal models.
We derive individual treatment effect through deconvolution of population data and develop new solutions for dosing decision support at the point of care with our physiologically-based Quantitative Systems Pharmacology Platforms.
News & Events
“The development of comprehensive digital disease platforms through data integration in the pharmaceutical- & life sciences can be considered Moonshot Projects. In most cases the development and application of our physiologically-based QSP platforms to support our customers is a collaborative effort built on the shoulders of the OPEN community.”
Check out our News & Events to follow the journey we are taking to achieve our mission and how we contribute to the OPEN community.
We will be giving two workshops on PBPK and PBPK/PD (PB-QSP) using PK-Sim and MoBi, and will present on leveraging PBPK for QSP in pediatrics.Meet us at our booth if you want to learn how you can leverage PBPK/PD platforms for your drug development program. ...
esqLABS is running a one-day hands-on PK-Sim® & MoBi® workshop on PBPK/PD (PB-QSP) of ADCs in oncology research on Saturday 19th of October at the Rosen Shingle Creek Hotel in Orlando, FL, US, as a satellite meeting to ACOP 10 2019. PB-QSP aka PBPK/PD, the...
What we offer
esqLABS develops and utilizes OPEN-SOURCE software to create physiologically-based QSP platforms as value-generating, holistic Modeling & Simulation solutions to support our customers decision making process along the entire life cycle of pharmaceutical products from research through development and at the point of care.
Our professional Network
esqLABS is an active member of the R & Open-Systems-Pharmacology community. We believe free and open source software is a foundation for innovative and important work in science, education, and industry. The many customers, partners, funding bodies, and networks who value our work help us contribute to this community.
Our research is supported by: Federal Ministry for Economic Affairs and Energy (Bundesministerium für Wirtschaft und Energie) and the Federal Ministry for Education and Research (Bundesministerium für Bildung und Forschung) according to a decision of the German Federal Parliament.